CXCL14 and neoplasm: These findings are in keeping with the results of our survival analyses of TCGA (Provisional) and the GSE21032 cohorts, which demonstrated that higher than average levels of expression of CXCL14 in bulk tumor tissue is associated with an increased risk of recurrence.